AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection

Aortic dissection has acute onset and high mortality, with immunoinflammatory response driving lesion progression. Current perioperative anti-inflammatory therapies are mostly empirical and poorly targeted, and AI-assisted typing lacks a complete clinical translation pathway. This study integrates multi-dimensional data to construct an AI immunoinflammatory subtyping system, enabling rapid subtyping and establishing a "subtyping-target-treatment" closed loop for emergency needs. Using a prospective multicenter RCT, 300 patients are randomly divided into two groups: the experimental group receives subtyping-based precision therapy, while the control group uses empirical strategies (treatment of physician's choice). It observes 7-day postoperative SOFA score, SIRS and other prognostic indicators to provide evidence-based support for precision treatment.

NCT Number	NCT07382375
Lead Sponsor	Nanjing Medical University Collaborators: The First Affiliated Hospital with Nanjing Medical University, The Third Affiliated Hospital of Soochow University, West China Hospital, Fujian Medical University Union Hospital, Shanghai East Hospital, Beijing Anzhen Hospital, Second Affiliated Hospital of Nanchang University
Conditions	Aortic Aneurysm and Dissection
Enrollment	300 participants
Start Date	2027-12-31
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-02